Research
Our cancer and blood disease multidisciplinary teams apply the latest diagnostic tools and molecular analytics to optimize treatment recommendations. We provide a robust portfolio of clinical trials that bring promising new agents to our patients, including cellular and immune-based therapy. We offer a Sickle Cell Disease program and an Adult Comprehensive Bleeding Disorders Center to complement our long-standing excellence in managing hemostatic and thrombotic disorders.
Division Scientists
The Division of Hematology and Oncology Faculty includes diverse researchers who apply the latest diagnostic tools and molecular analytics to optimize treatment recommendations. These investigators are pioneering the technologies, therapies, and care pathways that continue to benefit patients today and tomorrow. See our Division Research faculty below.